Trial Profile
An open-label, randomized, 3-way crossover study to assess the effect of colesevelam HCl (Welchol) 3750 mg on the single dose pharmacokinetics of phenytoin sodium ER 300 mg in healthy human adult subjects.
Status:
Completed
Phase of Trial:
Phase IV
Latest Information Update: 21 Jan 2019
Price :
$35
*
At a glance
- Drugs Colesevelam (Primary) ; Phenytoin
- Indications Epilepsy; Hypercholesterolaemia; Type 2 diabetes mellitus
- Focus Pharmacokinetics
- Sponsors Daiichi Sankyo Company
- 09 Dec 2010 Status changed from active, no longer recruiting to completed as reported by Clinical Trials Registry - India record.
- 10 Jun 2010 Status changed from not yet recruiting to active, no longer recruiting as reported by Clinical Trials Registry - India record.
- 15 Mar 2010 New trial record